ONI

See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue.

Founded 2016

Oxford, United Kingdom 210 employees Series B Total: $109.40M Biotechnology, Life Sciences

General Information

Company Name ONI

Founded Year 2016

Location

Oxford, United Kingdom

Employees 210

Industries Biotechnology, Life Sciences

Funding Stage Series B

Business Model B2B, SaaS, D2C

Revenue Model Product Sales, Subscription, Service Fee

Hiring 3 roles posted in the month to 26 Sep 2026

Social

BounceWatch is an independent company data service, not affiliated with ONI. To contact ONI, visit oni.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ONI compare?

A PDF of ONI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last six months. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ONI soon?

A one-page PDF brief: what it does, key facts, the last year of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 25, 2026

ONI is participating as an exhibitor at the I2KxBINA2026 event in Madison, Wisconsin, from September 27 to October 2, 2026, showcasing super-resolution imaging.

Actively Hiring Sep 23, 2026

Hiring for 3 positions in the last 30 days.

Feature Release Sep 21, 2026

ONI is highlighting how their super-resolution imaging workflow incorporates automated fluidics, imaging, and analysis to achieve more automated, reproducible, and scalable 2D and 3D imaging, reduc…

Award Received Sep 17, 2026

ONI has been honored as a 2026 WIRED Trailblazer by WIRED Consulting, recognizing its innovation and positive change.

Get alerts when ONI shows new signals

About ONI

ONI, founded in 2016, is a pioneering company headquartered in the United Kingdom, operating at the intersection of Biotechnology and Life Sciences. Their core innovation is The Nanoimager, the world's first desktop compatible compact super-resolution microscope, designed to provide unprecedented visibility into proteins, DNA, and RNA within nanoparticles, viruses, bacteria, cells, and tissue.

ONI's mission is to democratize access to advanced scientific tools, fueled by a drive to push the boundaries of scientific discovery through affordability and accessibility. The company's commitment manifests in their continuous effort to lower barriers for researchers seeking to ask and answer previously unapproachable questions.

In its latest financial milestone, ONI secured a $75.00M Series B investment on 24 December 2021, led by prominent investors such as Arch Venture Partners, Casdin Capital, Axon Ventures, Oxford Science Enterprises, Section 32, Vertical Venture Partners, and Artis Ventures (AV). This substantial backing underscores the market confidence in ONI's potential to transform molecular research landscapes.

Taxonomy: super-resolution microscopy, fluorescence imaging, single-molecule imaging, localization microscopy, nanotechnology, molecular research, scientific instrumentation, life sciences, academic research tools, clinical research tools, accessible technology, scientific discovery, nanoparticle imaging, microscopic visualization

Services & Products

High-resolution Imaging Solutions

Data Analysis and Visualization

Cloud-based Collaboration Platform

Sample Characterization Services

Microscopy Training and Support

Target Customers

Research Scientists Biotechnologists Pharmaceutical Researchers Microscopy Technicians Academia and Research Institutions

Funding Rounds & Investors (6)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$75.00M	7	Arch Venture Partners, Casdin Capital +5	24 Dec 2021
Series A	$5.00M	1	Casdin Capital	01 Sep 2020
Series A	$24.00M	5	Casdin Capital, GT Healthcare Capital Partners +3	13 Jul 2018
Funding Round	Undisclosed	1	Future Planet Capital	01 May 2018
Seed Round	$3.70M	2	GT Healthcare Capital Partners, Oxford Science Enterprises	03 Apr 2017
Seed Round	$1.70M	1	Oxford Science Enterprises	01 May 2016

ONI Alternatives & Competitors

View All Alternatives

ONI vs

LUMICKS The Netherlands

See more. Know more.

Debt Financing

123 employees

Biotechnology, Life Sciences

Compare ONI vs LUMICKS

ONI vs

Eikon Therapeutics United States

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing break...

Series D

429 employees

Biotechnology, Health Care

Compare ONI vs Eikon Therapeutics

ONI vs

Refeyn United Kingdom

Accelerating discovery and revolutionizing single-molecule bioanalytics with mass photometry.

Series A

166 employees

Biotechnology, Life Sciences

Compare ONI vs Refeyn

Also compare with:

Discover Echo Inc. View all alternatives

FAQ About ONI

See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue.

ONI was founded in 2016.

ONI is headquartered in Oxford, United Kingdom.

ONI operates in Biotechnology and Life Sciences. Its work centres on super-resolution microscopy, fluorescence imaging, single-molecule imaging and localization microscopy. Its customers include Research Scientists, Biotechnologists and Pharmaceutical Researchers.

ONI has a B2B, SaaS and D2C business model. Its revenue comes from Product Sales, Subscription and Service Fee.

ONI has approximately 210 employees.

ONI has completed 6 funding rounds, raising a total of $109.40M. The latest funding stage is Series B.

ONI offers: High-resolution Imaging Solutions, Data Analysis and Visualization, Cloud-based Collaboration Platform, Sample Characterization Services, Microscopy Training and Support.

Top alternatives and competitors to ONI include LUMICKS, Eikon Therapeutics, Refeyn, Cairn Research Ltd, Discover Echo Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ONI and LUMICKS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ONI, https://bouncewatch.com/company/oni, updated 26 September 2026. When citing, please name BounceWatch and link this page.

ONI

General Information

Discover More

What changed at ONI recently?

About ONI

Services & Products

Target Customers

Funding Rounds & Investors (6)

ONI Alternatives & Competitors

FAQ About ONI